Free Trial

Akoya Biosciences (AKYA) SEC Filings & 10K Form

Akoya Biosciences logo
$2.16 0.00 (0.00%)
(As of 11/20/2024 ET)

Recent Akoya Biosciences SEC Filings

DateFilerForm TypeView
11/04/2024
6:39 AM
Akoya Biosciences (Subject)
Schindel Yair Chaim (Filed by)
Form SC 13G/A
10/04/2024
5:44 PM
Akoya Biosciences (Issuer)
Mendel Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
8:40 PM
Akoya Biosciences (Issuer)
BAMFORD PASCAL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
8:41 PM
Akoya Biosciences (Issuer)
BAMFORD PASCAL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
9:45 AM
Akoya Biosciences (Subject)
Blue Water Life Science Advisors, LP (Filed by)
Form SC 13G
06/11/2024
3:36 PM
Akoya Biosciences (Subject)
McKelligon Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
8:56 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:53 PM
Akoya Biosciences (Issuer)
Mendel Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:54 PM
Akoya Biosciences (Issuer)
LAI GOLDMAN MYLA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:55 PM
Akoya Biosciences (Issuer)
SCHNETTLER THOMAS P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:56 PM
Akoya Biosciences (Issuer)
Winkler Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:57 PM
Akoya Biosciences (Issuer)
SHEPLER ROBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:58 PM
Akoya Biosciences (Issuer)
Raffin Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
5:03 AM
Akoya Biosciences (Filer)
Form DEF 14A
04/23/2024
5:04 AM
Akoya Biosciences (Filer)
Form DEFA14A
04/23/2024
5:05 AM
Akoya Biosciences (Filer)
Form ARS
03/25/2024
4:14 PM
Akoya Biosciences (Issuer)
Ramachandran Niro Ph.D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:16 PM
Akoya Biosciences (Issuer)
Pla Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:12 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:51 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4/A
03/22/2024
4:54 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
4:56 PM
Akoya Biosciences (Subject)
McKelligon Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2024
7:40 PM
Akoya Biosciences (Issuer)
SHEPLER ROBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
7:41 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:15 PM
Akoya Biosciences (Subject)
McKelligon Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
5:01 AM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4/A
03/01/2024
8:58 PM
Akoya Biosciences (Issuer)
Ek John Frederick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
8:52 PM
Akoya Biosciences (Issuer)
Ramachandran Niro Ph.D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
8:52 PM
Akoya Biosciences (Issuer)
Pla Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
8:53 PM
Akoya Biosciences (Issuer)
Kamocsay Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
8:21 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
8:11 AM
Akoya Biosciences (Subject)
PSC Capital Partners LLC (Filed by)
Form SC 13G/A
01/08/2024
5:02 AM
Akoya Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
7:50 AM
Akoya Biosciences (Subject)
Schindel Yair Chaim (Filed by)
Form SC 13G/A
12/20/2023
6:16 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
3:24 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
5:33 PM
Akoya Biosciences (Subject)
McKelligon Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2023
4:40 PM
Akoya Biosciences (Issuer)
Kamocsay Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
4:41 PM
Akoya Biosciences (Issuer)
Pla Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AKYA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners